Improved nutrient intake following implementation of the consensus standardised parenteral nutrition formulations in

Srinivas Bolisetty1,2,3, Pramod Pharande4,5, Lakshman Nirthanakumaran6

  • 1Division of Newborn Services, Royal Hospital for Women, Sydney, Australia. Srinivas.bolisetty@sesiahs.health.nsw.gov.au.

BMC Pediatrics
|December 18, 2014
PubMed

Insights

New standardized parenteral nutrition (SPN) formulations improved protein and caloric intake and weight gain in preterm infants. However, day 1 protein intake did not meet the consensus goal.

Area of Science:

  • Neonatal Intensive Care Medicine
  • Pediatric Nutrition
  • Clinical Nutrition

Background:

  • Standardized parenteral nutrition (SPN) formulations were implemented in New South Wales neonatal intensive care units in July 2011.
  • The implementation followed consensus group recommendations to improve neonatal care.

Purpose of the Study:

  • To evaluate the efficacy and safety of new consensus SPN formulations.
  • To assess the impact of SPN on preterm infants born before 32 weeks gestation.

Main Methods:

  • A before-after intervention study design was employed.
  • Data from a post-consensus cohort (2011-2012) were prospectively collected.
  • Data were compared retrospectively with a pre-consensus cohort (2010).

Main Results:

  • The post-consensus group initiated parenteral nutrition (PN) significantly earlier (6 vs. 11 hours).
  • Higher protein (1.34 vs. 0.49 g/kg on day 1) and caloric intake were observed.
  • Greater weight gain (285 vs. 220 g) in the first 4 weeks was noted, with reduced fluid and lipid therapy duration.

Conclusions:

  • New consensus SPN solutions enhanced protein intake within the first 7 days and promoted greater weight gain in preterm infants.
  • Protein intake on day 1 remained below the consensus target of 2 g/kg/day.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.9K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.9K
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
2.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K